Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Parkinson disease

Defining PD subtypes — a step toward personalized management?

Nature Reviews Neurology volume 13, pages 454–455 (2017)Cite this article

Subjects

A recent article published in Brain proposes a clinical method for subtyping Parkinson disease cases on an individual basis, with implications for better patient stratification for personalized medicine. The authors report biological validity in terms of imaging and cerebrospinal fluid parameters, but long-term predictive validity remains to be established.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Foltynie, T., Brayne, C. & Barker, R. A. The heterogeneity of idiopathic Parkinson's disease. J. Neurol. 249, 138–145 (2002).

    Article  Google Scholar 

  2. Fereshtehnejad, S. M., Zeighami, Y., Dagher, A. & Postuma, R. B. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression. Brain http://dx.doi.org/10.1093/brain/awx118 (2017).

  3. Lewis, S. J. et al. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J. Neurol. Neurosurg. Psychiatry 76, 343–348 (2005).

    Article  CAS  Google Scholar 

  4. van Rooden, S. M. et al. The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov. Disord. 25, 969–978 (2010).

    Article  Google Scholar 

  5. Graham, J. M. & Sagar, H. J. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov. Disord. 14, 10–20 (1999).

    Article  CAS  Google Scholar 

  6. Erro, R. et al. Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. Parkinsonism Relat. Disord. 28, 137–140 (2016).

    Article  Google Scholar 

  7. Foltynie, T., Brayne, C. E., Robbins, T. W. & Barker, R. A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127, 550–560 (2004).

    Article  Google Scholar 

  8. Collins, L. M. & Williams-Gray, C. H. The genetic basis of cognitive impairment and dementia in Parkinson's disease. Front. Psychiatry 7, 89 (2016).

    Article  Google Scholar 

  9. Velseboer, D. C. et al. Development and external validation of a prognostic model in newly diagnosed Parkinson disease. Neurology 86, 986–993 (2016).

    Article  Google Scholar 

  10. Liu, G. et al. Prediction of cognition in Parkinson's disease with a clinical–genetic score: longitudinal analysis of nine cohorts. Lancet Neurol. http://dx.doi.org/10.1016/S1474-4422(17)30122-9 (2017).

Download references

Acknowledgements

The work of the authors is supported by the NIHR Cambridge Biomedical Research Centre and the Wellcome Trust–Medical Research Council Cambridge Stem Cell Institute.

Author information

Authors and Affiliations

  1. Department of Clinical Neurosciences, Caroline H. Williams-Gray and Roger A. Barker are at the John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK.,

    Caroline H. Williams-Gray & Roger A. Barker

Authors
  1. Caroline H. Williams-Gray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger A. Barker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caroline H. Williams-Gray.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams-Gray, C., Barker, R. Defining PD subtypes — a step toward personalized management?. Nat Rev Neurol 13, 454–455 (2017). https://doi.org/10.1038/nrneurol.2017.98

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2017.98

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research